November 2, 2022

Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone

JWJian WangSichuan University XYXiaomin YanThird Affiliated Hospital of Guangzhou Medical University LZLi ZhuStanford University

Key Points

Key points are not available for this paper at this time.

Abstract

Over 70% of GZ CHB patients had significant histological disease. We recommend antiviral treatment for HBeAg-positive and HBeAg-negative GZ CHB patients with high PT.

AIに質問

Bookmark

View Full Paper

Cite This Study

Wang et al. (Wed,) studied this question.

synapsesocial.com/papers/69dba401498b35d3e6a3cebf https://doi.org/https://doi.org/10.1111/apt.17272

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡2006 · 4,898 citations
2Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study2021 · 38 citations
3Management of chronic hepatitis B2003 · 258 citations
4Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study2018 · 1,747 citations
5Natural history and disease progression in Chinese chronic hepatitis B patients in immune‐tolerant phase†2007 · 272 citations

AIに質問

Bookmark

View Full Paper